mixture for extraction, thus making unlikely the formation of mixed methyl-and ethyl-ester derivatives (4). We believe that this procedure can be of value for the accurate routine analysis of urinary porphyrins.
AnomalousResultson Usingan InhibitorMethodfor the

Determination of Pancreatic Isoenzymes
To the Editor:
We report some anomalous results obtained whilst carrying out a study to assess the value of an isoamylase kit (Pharmacia Diagnostics, Uppsala, Sweden) in the diagnosis of acute pancreatitis. The kit involvesa wheat protein that inhibits the salivary and pancreatic isoamylase by about 80% and
25%,respectively.
Pure pancreatic and salivary isoamylases are supplied,and by use of the following equations it should be possible to calculate the actual activity of the isoen.zyme in a sample: The basic procedure is as follows: Add 5 mL of 0.2 mol/L HC1 to 5.0 mL of urine and pass the mixture through a "Sep-Pak C 18" cartridge (Waters Associates, Milford, MA 01757), previously pre-activated according to the manufacturer's instructions.
Keep the flow rate through the cartridge at about 10 mLfmin.
Flush the Sep-Pak with 10 mL of glycine HC1 buffer (0.1 moliL, pH 2.0), then remove excess buffer by passing about 20 mL of air through the cartridge. Elute the porphyrins with about 8 mL of methanol. Cautiously add 0.5 mL of 18 molIL sulfuric acid to the eluate, dilute to 10 mL with methanol, and let react for 1 h at 37 #{176}C. Then dilute the mixture, containing the now-esterified porphyrins, to 50 mL with water. Pass this solution through a second pre-activated Sep-Pak C18 cartridge, and flush the cartridge with 10 mL of water. Elute the porphyrin methyl esters with 4 mL of chloroform. Transfer the choloroform containing the porphyrin methyl esters to a dry tube with a pipette, to separate it from the overlying thin film of water. Evaporate the chloroform under a stream of nitrogen. The Sep-Pak C18 used in isolating the porphyrin methyl esters can be re-used after the residual yellowish material is removed by flushing with 10 mL of methanol, followed by 5 mL of water.
Re-dissolve the dry porphyrin-containing residue obtained with this pro- We found losses to be <1.5% and not selective for any of the compounds. These was no appreciable increase in losses for total porphyrin concentrations up to 10 mol/L or more. We evaluated the precision of the method by assaying a sample containing, per liter, 1.25 mol of uroporphyrin,
1.6 imol of heptacarboxyl-, 0.12 mol of hexacarboxyl-, and 0.14 mol of pentacarboxyl-porphyrin and 0.43 mol of coproporphyrin. The within-run CV was 1.3% (n = 15) for each of the compounds tested; it was 5.7% (n = 10) between-run. This procedure makes preparation and isolation of porphyrin methyl esters, starting from urine samples, more convenient and reliable. Chloroform is not added directly to the esterification where P (U/L) is the activity of pancreatic isoamylase S (U/L) is the activity of salivary isoamylase R (U/L) is the activity remaining after addition of inhibitor T (U/L) is the total amylase activity a is the RIT ratio for pure pancreatic standard b is the RIT ratio for pure salivary standard
The mean RI].' ratios (and SD) for pure pancreatic (n = 18) and salivary (n = 18) standards, However, the R/T ratios for the latter exceeded those for the pure pancreatic standard, a result that is clearly anomalous and prevents the calculation of individual activities.
The pure standards have only been recently introduced. Before this time, we used a nonlinear standard curve, observed R/T ratios vs known P/S ratios. Evaluators of the Pharmacia kit have described specimens with R/T ratiosgreater than that of the top P/S standard (1-4). One of these (1) attributed this to the imprecision of the method. However, our results clearly show that there is a significant difference (p < 0.001 by unpaired t-test) between the R1T ratios for the pure The observations of Vladutiu (1) do not allow any conclusions as to the histological pattern of testicular germ cell tumors from the finding of increased LDH (1.1.1.27) and (or) LDH-1 (only) in serum. This agrees with our experience (2). We found no statistically significant difference between LDH activity in the serum of 11 patients with lesions from seminomas, five patients with embryonal carcinoma, or 21 with other nonseminomatous testicular genii cell tumors. Of 11 patients with seminomas, five had increased LDH but only one had increased LDH-1 (the only increased isoenzyme, 72% of the 920 U/L total) in the serum. Of 26 patients with nonseminomatous testicular germ cell tumors, 10 had increased LDH and, of these, only three had increased LDH-1 only. One of these with seminoma + embryonal carcinoma + yolk sac tumor had 63% LDH-1 of the total 610 U of LDH per liter, and one with seminoma + embryonal carcinoma + immature teratoma had 59% of the 680 UIL total. The third patient, with lesions from only yolk sac tumor of the testis, had LDH-1 that was 87% of the 570 UIL total LDH in serum collected from a peripheral arm
